These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 36875869)

  • 1. The Senolytic Drug Fisetin Attenuates Bone Degeneration in the
    Hambright WS; Mu X; Gao X; Guo P; Kawakami Y; Mitchell J; Mullen M; Nelson AL; Bahney C; Nishimura H; Hellwinkel J; Eck A; Huard J
    J Osteoporos; 2023; 2023():5572754. PubMed ID: 36875869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of senescent fibro-adipogenic progenitors in progeria-aged muscle by senolytics rescues the function of muscle stem cells.
    Liu L; Yue X; Sun Z; Hambright WS; Wei J; Li Y; Matre P; Cui Y; Wang Z; Rodney G; Huard J; Robbins PD; Mu X
    J Cachexia Sarcopenia Muscle; 2022 Dec; 13(6):3137-3148. PubMed ID: 36218080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Senolytic drugs: from discovery to translation.
    Kirkland JL; Tchkonia T
    J Intern Med; 2020 Nov; 288(5):518-536. PubMed ID: 32686219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular Senescence: A Translational Perspective.
    Kirkland JL; Tchkonia T
    EBioMedicine; 2017 Jul; 21():21-28. PubMed ID: 28416161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The senolytic agent ABT263 ameliorates osteoporosis caused by active vitamin D insufficiency through selective clearance of senescent skeletal cells.
    Yang C; Qiao W; Xue Q; Goltzman D; Miao D; Dong Z
    J Orthop Translat; 2024 Nov; 49():107-118. PubMed ID: 39430127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted Reduction of Senescent Cell Burden Alleviates Focal Radiotherapy-Related Bone Loss.
    Chandra A; Lagnado AB; Farr JN; Monroe DG; Park S; Hachfeld C; Tchkonia T; Kirkland JL; Khosla S; Passos JF; Pignolo RJ
    J Bone Miner Res; 2020 Jun; 35(6):1119-1131. PubMed ID: 32023351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease.
    Hickson LJ; Langhi Prata LGP; Bobart SA; Evans TK; Giorgadze N; Hashmi SK; Herrmann SM; Jensen MD; Jia Q; Jordan KL; Kellogg TA; Khosla S; Koerber DM; Lagnado AB; Lawson DK; LeBrasseur NK; Lerman LO; McDonald KM; McKenzie TJ; Passos JF; Pignolo RJ; Pirtskhalava T; Saadiq IM; Schaefer KK; Textor SC; Victorelli SG; Volkman TL; Xue A; Wentworth MA; Wissler Gerdes EO; Zhu Y; Tchkonia T; Kirkland JL
    EBioMedicine; 2019 Sep; 47():446-456. PubMed ID: 31542391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orally-active, clinically-translatable senolytics restore α-Klotho in mice and humans.
    Zhu Y; Prata LGPL; Gerdes EOW; Netto JME; Pirtskhalava T; Giorgadze N; Tripathi U; Inman CL; Johnson KO; Xue A; Palmer AK; Chen T; Schaefer K; Justice JN; Nambiar AM; Musi N; Kritchevsky SB; Chen J; Khosla S; Jurk D; Schafer MJ; Tchkonia T; Kirkland JL
    EBioMedicine; 2022 Mar; 77():103912. PubMed ID: 35292270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular Senescence and Senolytic Agents: Recent Updates on Their Role and Applications.
    Chandrakar L; Ambatwar R; Khatik GL
    Curr Top Med Chem; 2024; 24(2):157-178. PubMed ID: 38037999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of mitochondrial dysfunction in Hutchinson-Gilford progeria syndrome through use of stable isotope labeling with amino acids in cell culture.
    Rivera-Torres J; Acín-Perez R; Cabezas-Sánchez P; Osorio FG; Gonzalez-Gómez C; Megias D; Cámara C; López-Otín C; Enríquez JA; Luque-García JL; Andrés V
    J Proteomics; 2013 Oct; 91():466-77. PubMed ID: 23969228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Achilles' heel of senescent cells: from transcriptome to senolytic drugs.
    Zhu Y; Tchkonia T; Pirtskhalava T; Gower AC; Ding H; Giorgadze N; Palmer AK; Ikeno Y; Hubbard GB; Lenburg M; O'Hara SP; LaRusso NF; Miller JD; Roos CM; Verzosa GC; LeBrasseur NK; Wren JD; Farr JN; Khosla S; Stout MB; McGowan SJ; Fuhrmann-Stroissnigg H; Gurkar AU; Zhao J; Colangelo D; Dorronsoro A; Ling YY; Barghouthy AS; Navarro DC; Sano T; Robbins PD; Niedernhofer LJ; Kirkland JL
    Aging Cell; 2015 Aug; 14(4):644-58. PubMed ID: 25754370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fisetin is a senotherapeutic that extends health and lifespan.
    Yousefzadeh MJ; Zhu Y; McGowan SJ; Angelini L; Fuhrmann-Stroissnigg H; Xu M; Ling YY; Melos KI; Pirtskhalava T; Inman CL; McGuckian C; Wade EA; Kato JI; Grassi D; Wentworth M; Burd CE; Arriaga EA; Ladiges WL; Tchkonia T; Kirkland JL; Robbins PD; Niedernhofer LJ
    EBioMedicine; 2018 Oct; 36():18-28. PubMed ID: 30279143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short senolytic or senostatic interventions rescue progression of radiation-induced frailty and premature ageing in mice.
    Fielder E; Wan T; Alimohammadiha G; Ishaq A; Low E; Weigand BM; Kelly G; Parker C; Griffin B; Jurk D; Korolchuk VI; von Zglinicki T; Miwa S
    Elife; 2022 May; 11():. PubMed ID: 35507395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sexual dimorphic metabolic and cognitive responses of C57BL/6 mice to Fisetin or Dasatinib and quercetin cocktail oral treatment.
    Fang Y; Medina D; Stockwell R; McFadden S; Quinn K; Peck MR; Bartke A; Hascup KN; Hascup ER
    Geroscience; 2023 Oct; 45(5):2835-2850. PubMed ID: 37296266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for late phase preclinical and early clinical trials of senolytics.
    Wissler Gerdes EO; Misra A; Netto JME; Tchkonia T; Kirkland JL
    Mech Ageing Dev; 2021 Dec; 200():111591. PubMed ID: 34699859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine Progeria Model Exhibits Delayed Fracture Healing with Dysregulated Local Immune Response.
    Duke VR; Philippon MJ; Lind DRG; Kasler H; Yamaura K; Huard M; Czachor M; Hollenbeck J; Brown J; Garcia A; Fukase N; Marcucio RS; Nelson AL; Hambright WS; Snapper DM; Huard J; Bahney CS
    bioRxiv; 2024 May; ():. PubMed ID: 38854043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of gingerenone A as a novel senolytic compound.
    Moaddel R; Rossi M; Rodriguez S; Munk R; Khadeer M; Abdelmohsen K; Gorospe M; Ferrucci L
    PLoS One; 2022; 17(3):e0266135. PubMed ID: 35349590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of the molecular mechanism of quercetin and dasatinib combination as senolytic in alleviating age-related and kidney diseases.
    Alharbi KS; Afzal O; Altamimi ASA; Almalki WH; Kazmi I; Al-Abbasi FA; Alzarea SI; Makeen HA; Albratty M
    J Food Biochem; 2022 Dec; 46(12):e14471. PubMed ID: 36268851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery, development, and future application of senolytics: theories and predictions.
    Wissler Gerdes EO; Zhu Y; Tchkonia T; Kirkland JL
    FEBS J; 2020 Jun; 287(12):2418-2427. PubMed ID: 32112672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging Therapeutic Approaches to Target the Dark Side of Senescent Cells: New Hopes to Treat Aging as a Disease and to Delay Age-Related Pathologies.
    Khalil R; Diab-Assaf M; Lemaitre JM
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.